DK0531419T3 - Bistriazener som kemoterapeutiske midler - Google Patents

Bistriazener som kemoterapeutiske midler

Info

Publication number
DK0531419T3
DK0531419T3 DK91910672T DK91910672T DK0531419T3 DK 0531419 T3 DK0531419 T3 DK 0531419T3 DK 91910672 T DK91910672 T DK 91910672T DK 91910672 T DK91910672 T DK 91910672T DK 0531419 T3 DK0531419 T3 DK 0531419T3
Authority
DK
Denmark
Prior art keywords
compounds
bistriazene
cancer
bistriazenes
chemotherapeutic agents
Prior art date
Application number
DK91910672T
Other languages
English (en)
Inventor
Christopher J Michejda
Jeffrey J Blumenstein
Original Assignee
Us Commerce
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Us Commerce filed Critical Us Commerce
Application granted granted Critical
Publication of DK0531419T3 publication Critical patent/DK0531419T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C245/00—Compounds containing chains of at least two nitrogen atoms with at least one nitrogen-to-nitrogen multiple bond
    • C07C245/22—Compounds containing chains of at least two nitrogen atoms with at least one nitrogen-to-nitrogen multiple bond containing chains of three or more nitrogen atoms with one or more nitrogen-to-nitrogen double bonds
    • C07C245/24—Chains of only three nitrogen atoms, e.g. diazoamines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14—The ring being saturated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
DK91910672T 1990-05-24 1991-05-22 Bistriazener som kemoterapeutiske midler DK0531419T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US52791590A 1990-05-24 1990-05-24
PCT/US1991/003445 WO1991017753A1 (en) 1990-05-24 1991-05-22 Bistriazenes as chemotherapeutic agents

Publications (1)

Publication Number Publication Date
DK0531419T3 true DK0531419T3 (da) 1999-11-29

Family

ID=24103474

Family Applications (1)

Application Number Title Priority Date Filing Date
DK91910672T DK0531419T3 (da) 1990-05-24 1991-05-22 Bistriazener som kemoterapeutiske midler

Country Status (10)

Country Link
US (2) US5672593A (da)
EP (1) EP0531419B1 (da)
JP (1) JPH05506452A (da)
AT (1) ATE182468T1 (da)
AU (1) AU642273B2 (da)
CA (1) CA2083148C (da)
DE (1) DE69131481T2 (da)
DK (1) DK0531419T3 (da)
ES (1) ES2134778T3 (da)
WO (1) WO1991017753A1 (da)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5808038A (en) * 1990-05-24 1998-09-15 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Bistriazenes as chemotherapeutic agents
DK0626943T3 (da) * 1991-10-31 2000-04-17 Us Health Bistriazener som kemoterapimidler
US5548070A (en) * 1993-07-22 1996-08-20 Wacker-Chemie Gmbh Organosilicon compounds having triazene groups
DE19508076C2 (de) * 1995-03-08 1998-04-30 Csb Syst Software Entwicklung Schaltungsanordnung zur Integration eines Sprachsystems in EDV-Systeme und Telefonanlagen, die an das öffentliche Telefonnetz angeschlossen sind
ZA973642B (en) * 1996-04-26 1997-11-25 Merck & Co Inc DNA vaccine formulations.
US6875907B2 (en) 2000-09-13 2005-04-05 Pioneer Hi-Bred International, Inc. Antimicrobial peptides and methods of use
AU2002331897A1 (en) 2001-09-27 2003-04-07 Pioneer Hi-Bred International, Inc. Phytate polynucleotides and methods of use
NZ535602A (en) 2002-04-08 2006-07-28 Pioneer Hi Bred Int Enhanced silk exsertion under stress in Zea mays plants
US7987056B2 (en) 2004-09-20 2011-07-26 The Regents Of The University Of Colorado, A Body Corporate Mixed-library parallel gene mapping quantitative micro-array technique for genome-wide identification of trait conferring genes
WO2010017598A1 (en) 2008-08-14 2010-02-18 Arana Therapeutics Limited Anti-il-12/il-23 antibodies
EP2557075A1 (de) 2011-08-09 2013-02-13 Trin Therapeutics GmbH Neue Triazenverbindungen zur Behandlung von Krebs
BR112014009968A2 (pt) 2011-10-25 2017-07-04 Du Pont método para redução do teor de acetato, arabinosidase e/ou ferulato em uma planta, método de modulação da concentração de carboidratos da planta em uma planta transgénica, método para alterar o teor de acetila e de reticulação nos tecidos das plantas, método para a produção de biomassa para a produção de biocombustíveis ou silagem, produto, forragem de planta

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3138521A (en) * 1960-10-04 1964-06-23 Gen Aniline & Film Corp Fungicidal method
CH482789A (de) * 1967-03-16 1969-12-15 Ciba Geigy Verfahren zur Herstellung neuer Disazofarbstoffpigmente
DE1793115A1 (de) * 1968-08-03 1972-02-03 Bayer Ag Neue Triazenderivate
DE3426644A1 (de) * 1984-07-19 1986-02-06 Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts, 6900 Heidelberg N,n-bis((1-aryl-3-methyltriazen-3-yl) methyl)ether
US4923970A (en) * 1988-03-28 1990-05-08 Bionetics Research, Inc. Substituted 1-(2-chloroethyl)-3-acyl-3-alkyltriazenes

Also Published As

Publication number Publication date
AU642273B2 (en) 1993-10-14
AU8089791A (en) 1991-12-10
EP0531419A1 (en) 1993-03-17
ES2134778T3 (es) 1999-10-16
CA2083148A1 (en) 1991-11-25
EP0531419A4 (en) 1994-04-06
DE69131481T2 (de) 1999-11-25
DE69131481D1 (de) 1999-09-02
ATE182468T1 (de) 1999-08-15
US5672593A (en) 1997-09-30
EP0531419B1 (en) 1999-07-28
US5731301A (en) 1998-03-24
JPH05506452A (ja) 1993-09-22
WO1991017753A1 (en) 1991-11-28
CA2083148C (en) 2002-01-01

Similar Documents

Publication Publication Date Title
BR9303993A (pt) Composto, processo para preparar o mesmo e composição farmacêutica
FI953467A (fi) Aminohappojohdannaisia, näitä yhdisteitä sisältävät lääkeaineet ja menetelmä niiden valmistamiseksi
FI931031A (fi) Mometasonfuroatmonohydrat, foerfarande foer dess framstaellning och farmaceutiska sammansaettningar
DK0531419T3 (da) Bistriazener som kemoterapeutiske midler
LU88348I2 (fr) Chlorhydrate d'esmolol (Brevibloc)
ATE45153T1 (de) Benzisoselenazolthione, verfahren zu ihrer herstellung und diese verbindungen enthaltende pharmazeutische produkte.
DE68913762T2 (de) Diarylverbindungen als antiatherosklerotische Mittel.
GR1001597B (el) Νέα βιολογικώς δραστικά παράγωγα εμπουρναμενίνης, φαρμακευτικές συν?έσεις οι οποίες περιέχουν αυτά και μέ?οδος δια την παρασκευή αυτών.
KR960703863A (ko) 암 치료용 신규 비스-나프탈이미드(New Bis-naphthalimides for the Treatment of Cancer)
AU7116781A (en) Para-substituted-3-phenoxy-1-alkoxycarbenyl-alkylamino- propanol-2 compounds
ES479059A1 (es) Procedimiento para preparar derivados del naftaleno.
DE69132578D1 (de) Cephemderivate
KR880007070A (ko) 백내장 치료용 약학 조성물
DK0626943T3 (da) Bistriazener som kemoterapimidler
FI884838A0 (fi) Nytt s-timololderivat och foerfarande foer dess framstaellning.
BR9305752A (pt) Composto composiçao farmaceutica e processo para a preparaçao de um composto de derivados alquila da trazodona
ES2062214T3 (es) Derivados de aminooligohidroxi inhibidores de renina.
KR890017363A (ko) 스트로빌루린 유도체, 이들의 제법 및 용도
BR9101973A (pt) Compostos quimicos,processo para a sua preparacao e composicoes farmaceutica e terapeutica
EP0043976A3 (en) Anti-tumor agent
ATE47863T1 (de) Makrolide derivate.
KR950702942A (ko) 암의 간전이 억제용 의약 조성물 및 간암 치료용 의약 조성물(pharmaceutical compositions for preventing liver metastasis of cancer and pharmaceutical composition for the treatment of liver cancer)
GB1333565A (en) Therapeutic compositions